Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter July 5, 2007

Role of visfatin, insulin-like growth factor-I and insulin in fetal growth

  • Despina D. Briana , Maria Boutsikou , Dimitrios Gourgiotis , Louiza Kontara , Stavroula Baka , Nicoletta Iacovidou , Dimitrios Hassiakos and Ariadne Malamitsi-Puchner

Abstract

Objective: IGF-I and insulin are the main regulators of intrauterine and postnatal growth. Adipose tissue secreted cytokines are implicated in intrauterine growth. The relevant function of the adipocytokine visfatin is unknown.

Materials and methods: Serum visfatin, IGF-I and insulin levels were measured by enzyme immunoassays in 40 singleton full-term fetuses and neonates on postnatal days 1(N1) and 4 (N4).

Results: No significant correlations exist between visfatin and IGF-I or insulin. N1 and N4 visfatin positively correlated with customized (adjusted) birth weight centiles (r=0.511, P=0.021, and r=0.597, P=0.005, respectively). Fetal and N1 IGF-I positively correlated with customized centiles (r=0.608, P<0.001 and r=0.485, P=0.006, respectively). Fetal insulin positively correlated with customized centiles (r=0.654, P=0.021).

Conclusions: Potential implication of visfatin in fetal growth is probably not mediated by IGF-I or insulin. Although a more active role cannot be excluded, visfatin may simply represent a marker of fat accumulation.


Corresponding author: Ariadne Malamitsi-Puchner, MD 19, Soultani Street GR-10682 Athens Greece Tel.: +30 6944443815 Fax: +30 2107233330 ;

Received: 2006-11-30
Revised: 2007-3-2
Accepted: 2007-4-18
Published Online: 2007-07-05
Published in Print: 2007-8-1

©2007 by Walter de Gruyter Berlin New York

Downloaded on 25.4.2024 from https://www.degruyter.com/document/doi/10.1515/JPM.2007.071/html
Scroll to top button